secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
CIK:        0001742927
Form:       8-K
Filed at:   2022-06-27T23:59:59+00:00
Accession:  0001437749-22-015928
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Reviva Pharmaceuticals CMO Marc Cantillon resigns effective July 5, 2022
------------------------------------------------------------------------

- Marc Cantillon resigns as Chief Medical Officer effective July 5, 2022, to pursue other opportunities.
- Resignation not due to disagreements with company operations, policies, or practices.
- Company has commenced search for new clinical management; will use independent consultants in the interim.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1742927/000143774922015928/0001437749-22-015928-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1742927/000143774922015928/rvph20220624_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-015928

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer